Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 20, 2003
Angiotensin II and the fibroproliferative response to acute lung injuryRichard P Marshall, Peter Gohlke, Rachel C Chambers, et al.
The British Journal of Dermatology|May 1, 1977
Phenothiazine therapy and plasma immunoreactive beta-MSH in schizophrenia and pruritic dermatosesA G Smith, S K Goolamali, A J Thody, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1991
[Cyclosporin A in atopic dermatitis: therapeutic effect and effect on allergic reactions are dissociated from each other]C S Munro, E M Higgins, J M Marks, et al.
The British Journal of Dermatology|January 1, 1991
Cyclosporin A in atopic dermatitis: therapeutic response is dissociated from effects on allergic reactionsC S Munro, E M Higgins, J M Marks, et al.
Molecular Human Reproduction|September 1, 1996
Hyaluronan, CD44 and its variant exons in human trophoblast invasion and placental angiogenesisR Goshen, I Ariel, S Shuster, et al.
The Journal of Investigative Dermatology|April 20, 2000
Reduced hyaluronan in keloid tissue and cultured keloid fibroblastsL J Meyer, S B Russell, J D Russell, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1975
The effect of chlorpromazine on the secretion of immunoreactive beta-MSH and prolactin in manN A Plummer, A J Thody, J L Burton, et al.
British Medical Journal|March 22, 1975
Plasma immunoreactive beta-melanocyte-stimulating hormone and skin pigmentation in chronic renal failureA G Smith, S Shuster, J S Comaish, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activityM G Belvisi, S L Wicks, C H Battram, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000
Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibodyL Weiss, S Slavin, S Reich, et al.
Pageof 22